Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[The diagnostic contribution of complementary tests].

C Chouaid1, B Housset

  • 1Service de Pneumologie, Hôpital Saint-Antoine, Paris.

Revue Des Maladies Respiratoires
|January 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Optimisation and validation of line-of-therapy advancement algorithms in advanced/metastatic non-small-cell lung cancer: an I-O Optimise study.

ESMO real world data and digital oncology·2026
Same author

Real-world 5-year outcomes with durvalumab after chemoradiotherapy in unresectable stage III NSCLC.

ESMO open·2026
Same author

Prediction of survival and outcomes with depth of response at 6 months in metastatic non-small-cell lung cancer patients treated with chemotherapy and immunotherapy combination: SPORE trial.

ESMO open·2026
Same author

Efficacy of first-line treatments for advanced pulmonary sarcomatoid carcinomas: a real-world analysis.

ESMO open·2025
Same author

Durvalumab after sequential chemoradiotherapy in unresectable stage III non-small-cell lung cancer-final analysis from the phase II PACIFIC-6 trial.

ESMO open·2025
Same author

[Influence of smoking on the efficacy of immunotherapy in advanced lung cancers].

Revue des maladies respiratoires·2025
Same journal

[French version of the guidelines for connective tissue disease-associated ILD].

Revue des maladies respiratoires·2026
Same journal

[Pulmonary expression of an asymptomatic lysosomal storage disorder].

Revue des maladies respiratoires·2026
Same journal

[Factors associated with FEV1 evolution in cystic fibrosis patients treated by CFTR modulator tritherapy].

Revue des maladies respiratoires·2026
Same journal

[Subacute pulmonary coccidioidomycosis: A differential diagnosis of lung cancer].

Revue des maladies respiratoires·2026
Same journal

[Relevance of the ACT score in severe asthma with obesity: A pilot study].

Revue des maladies respiratoires·2026
Same journal

[Automated analysis of mandibular movements for the screening of obstructive sleep apnea].

Revue des maladies respiratoires·2026
See all related articles

Choosing the right pneumology tests is challenging due to numerous options. This study explains decisional analysis principles like sensitivity, specificity, and Bayes

Area of Science:

  • Pulmonary Medicine
  • Medical Diagnostics
  • Decision Analysis

Context:

  • Pneumology involves a wide array of complementary diagnostic examinations.
  • Selecting the most appropriate tests for optimal patient investigation presents a significant challenge.
  • Establishing reliable reference values for diagnostic tests is crucial for accurate interpretation.

Purpose:

  • To elucidate the general principles of decisional analysis in the context of pneumology.
  • To guide the selection of appropriate diagnostic tests for respiratory conditions.
  • To enhance the interpretation of diagnostic results in clinical practice.

Summary:

  • Discusses key decisional analysis concepts: sensitivity, specificity, probability ratios, and odds ratio.

Related Experiment Videos

  • Explains the critical role of disease prevalence in interpreting test results using Bayes' theorem.
  • Illustrates practical applications of these principles for diagnosis and therapy in pneumology.

    • Impact:

    • Aims to improve the efficiency and accuracy of diagnostic test selection in pneumology.
    • Provides a framework for better understanding and applying diagnostic test performance metrics.
    • Facilitates more informed clinical decision-making in the management of pulmonary diseases.